BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 12858063)

  • 1. Cognitive dysfunction in multiple sclerosis: a review of recent developments.
    Bobholz JA; Rao SM
    Curr Opin Neurol; 2003 Jun; 16(3):283-8. PubMed ID: 12858063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognition in multiple sclerosis.
    Langdon DW
    Curr Opin Neurol; 2011 Jun; 24(3):244-9. PubMed ID: 21519256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in multiple sclerosis.
    Hoffmann S; Tittgemeyer M; von Cramon DY
    Curr Opin Neurol; 2007 Jun; 20(3):275-80. PubMed ID: 17495620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuropsychiatry of multiple sclerosis: a review of recent developments.
    Ghaffar O; Feinstein A
    Curr Opin Psychiatry; 2007 May; 20(3):278-85. PubMed ID: 17415083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive deficits in multiple sclerosis: a review of functional MRI studies.
    Caramia F; Tinelli E; Francia A; Pozzilli C
    Neurol Sci; 2010 Nov; 31(Suppl 2):S239-43. PubMed ID: 20694492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis.
    Benedict RH; Carone DA; Bakshi R
    J Neuroimaging; 2004 Jul; 14(3 Suppl):36S-45S. PubMed ID: 15228758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A critical analysis of neuroimaging studies in relation to cognitive performance in multiple sclerosis patients].
    Cruz-Gomez J; Belenguer-Benavides A; Gonzalez-Rosa JJ; Simon-Gozalbo A; Forn C
    Rev Neurol; 2011 Sep; 53(6):337-50. PubMed ID: 21894605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL
    J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis.
    Kalmar JH; Gaudino EA; Moore NB; Halper J; Deluca J
    Neuropsychology; 2008 Jul; 22(4):442-9. PubMed ID: 18590356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiorespiratory fitness: A predictor of cortical plasticity in multiple sclerosis.
    Prakash RS; Snook EM; Erickson KI; Colcombe SJ; Voss MW; Motl RW; Kramer AF
    Neuroimage; 2007 Feb; 34(3):1238-44. PubMed ID: 17134916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment in multiple sclerosis.
    Chiaravalloti ND; DeLuca J
    Lancet Neurol; 2008 Dec; 7(12):1139-51. PubMed ID: 19007738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in multiple sclerosis.
    Jongen PJ; Ter Horst AT; Brands AM
    Minerva Med; 2012 Apr; 103(2):73-96. PubMed ID: 22513513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI correlates of cognitive dysfunction in multiple sclerosis patients.
    Rovaris M; Filippi M
    J Neurovirol; 2000 May; 6 Suppl 2():S172-5. PubMed ID: 10871808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychological and neuropsychological problems in multiple sclerosis].
    BĂ©quet D; Taillia H; Clervoy P; Renard JL; Flocard F
    Bull Acad Natl Med; 2003; 187(4):683-94; discussion 695-7. PubMed ID: 14556476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns.
    Tiemann L; Penner IK; Haupts M; Schlegel U; Calabrese P
    Mult Scler; 2009 Oct; 15(10):1164-74. PubMed ID: 19667010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis.
    Porcel J; Montalban X
    J Neurol Sci; 2006 Jun; 245(1-2):177-81. PubMed ID: 16674980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive functioning in children and adolescents with multiple sclerosis.
    MacAllister WS; Belman AL; Milazzo M; Weisbrot DM; Christodoulou C; Scherl WF; Preston TE; Cianciulli C; Krupp LB
    Neurology; 2005 Apr; 64(8):1422-5. PubMed ID: 15851734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported executive dysfunction, neuropsychological impairment, and functional outcomes in multiple sclerosis.
    Basso MR; Shields IS; Lowery N; Ghormley C; Combs D; Arnett PA; Johnson J
    J Clin Exp Neuropsychol; 2008 Nov; 30(8):920-30. PubMed ID: 18608679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the prevalence of cognitive impairment in multiple sclerosis: implications for patient management.
    Penman MF
    Axone; 1991 Dec; 13(2):45-9. PubMed ID: 1764408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.